🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this trial is to compare the 3-year disease-free survival of...
Status
Unknown
Location
National Cancer Center, Cancer Hospital/Chinese Academy of Medical Sciences and Peking Union Medical College
Start Date
2019-02-22
Trial ID
NCT03876886
Treatments Being Tested
The study has a phase Ib and a phase II part. * The phase Ib aims to evalu...
Status
Completed
Location
Grand Hôpital de Charleroi
Start Date
2017-04-13
Trial ID
NCT03356860
Treatments Being Tested
The purpose of this trial is to compare the 3 years DFS of dose-dense epiru...
Status
Unknown
Location
Cancer institute and hospital Chinese academy of medical sciences
Start Date
2011-05
Trial ID
NCT01378533
Treatments Being Tested
This is a prospective, single center, randomized, open-labled stage III cli...
Status
Active Not Recruiting
Location
Fudan University Shanghai Cancer Center
Start Date
2020-03-05
Trial ID
NCT04296175
Treatments Being Tested
Primary aim: To compare the effect on pathologic complete response (pCR) ra...
Status
Active Not Recruiting
Location
Vejle Hospital
Start Date
2019-12-20
Trial ID
NCT04335669
Two regimen are currently considered to have highest efficacy for patients ...
Status
Completed
Location
NTC
Start Date
2014-12
Trial ID
NCT02125344
This study will evaluate the efficacy, safety, and pharmacokinetics of adju...
Status
Terminated
Location
John Muir Health Clinical Research Center
Start Date
2018-08-02
Trial ID
NCT03498716
Treatments Being Tested
In this trial we will evaluate ABI-007 with gemcitabine and epirubicin, uti...
Status
Completed
Location
Florida Cancer Specialists
Start Date
2005-09
Trial ID
NCT00193206
Treatments Being Tested
This multicenter, non-randomized, open-label, phase 2 study is designed to ...
Status
Completed
Location
University of South Alabama; Mitchell Cancer Institute
Start Date
2014-07-14
Trial ID
NCT02132949
Treatments Being Tested
Genomics assays that measure specific gene expression patterns in a patient...
Status
Completed
Location
University of South Alabama, Mitchell Cancer Institute
Start Date
2011-10
Trial ID
NCT01501487
Treatments Being Tested